Targeting Stage 4 Cancer beyond Chemo


Published on - Stage 4 Cancer is also known as Stage IV Cancer, which spread to various sites in the body. It is a complex type of cancer to treat, and it can involve many organ systems. Envita’s vast area of technologies options gives stage 4 cancer patients the most complete approach to their cancer.

Published in: Health & Medicine
  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Targeting Stage 4 Cancer beyond Chemo

  1. 1. Targeting Stage 4 Cancer beyond ChemoTargeting Stage 4 Cancer beyond ChemoOne tactic cancer cells and stage 4 cancers employ to develop and progress is by avoiding programmedcell death (apoptosis.) In a normal body, apoptosis is the naturally-occurring process by which the bodymaintains healthy tissue function by disposing of damaged cells. It is triggered by signals, including cellstress and DNA damage.In many cancer patients, we see the process of apoptosis averted. This allows cancer cells to continue toendure. In a healthy person, we may see apoptosis protect us from potential cancer situations up to10,000 times per day; so what we must ask ourselves is “why then do stage 4 cancer patients divert thisnatural process?”Mutations Bring About Stubborn and Resistant Stage 4 CancersBoth internal and external cellular triggers can commence apoptosis. To catalyze internally, the processrelies on protein p53. In the event of certain mutations to this protein’s gene, the protein can becomeinactive, thereby inhibiting internally-triggered apoptosis functionality. This mutation is seen in up to 50percent of all human cancers. By targeting this mutation, cancer treatments are enhanced significantly.Stage 4 Cancers May Dodge ChemotherapyIt is common knowledge that radiation’s and chemotherapy’s ability to damage cell DNA, indirectlypromotes apoptosis. However, cancer takes advantage of a tricky loophole to side-step what should beimminent trouble for its cells. As mutations to protein p53 can shut down apoptosis from within the cell, insuch circumstance, cancer cells can escape the harm of conventional stage 4 treatments meant to wipe itout.
  2. 2. Because Envita has seen this repeatedly over the last decade plus of working with the most difficultcancers, we have become proactive. Our protocols call for preventative treatments designed to overcomep53 oncogene mutations through specialized nutrition, and encouraging healthy apoptosis.Recognizing that nutritional, immunological, or impairments in toxin elimination deficiencies can createcancer-friendly environments is the first step. Taking action against the causes of these environments iswhat sets Envita apart.Launching an Offensive on CancerBy simultaneously catalyzing apoptosis outside and within the cell, it is possible to destroy cancer cellsthat were previously deemed conventional treatment-resistant. Depending upon the stage and cancertype, Envita has a variety of treatments to support mitochondria dysfunction – coupled with nutrientsemployed to restore healthy functionality. These unique treatments are a part of why Envita has such andimpressive track record against advanced and stage 4 cancers.Treatment Improved – Results AchievedEnvita’s Comprehensive Smart Oncology®(link to Envita cancer section) program integratessuccessful oncology combinations with our aggressive natural therapies that affect apoptosis in cancercells by using tumor destruction methods that actually rely solely on p53. Visit our PPMR process( link toEnvita home or ppmr) or contact us speak to one of our patient-care educators so that we can put animmediate plan in place for you.